SOURCE: London & Pacific Healthcare Inc.

February 14, 2007 16:00 ET

London & Pacific Healthcare, Inc. Announces Executive Management Team

EL SEGUNDO, CA -- (MARKET WIRE) -- February 14, 2007 -- London & Pacific Healthcare, Inc. ("London & Pacific") (the "Company") (PINKSHEETS: LDPH), a holding company that works with a select group of healthcare companies and organizations to create extraordinary growth, value and financial returns, today announced the members of the executive team that will lead the company into the next phase of growth.

Stuart Bruck, London & Pacific's Executive Chairman, has assembled a team of seasoned veterans with decades of combined management experience and entrepreneurial company builders who have taken a variety of healthcare companies and guided them to success. He founded London & Pacific and has over 30 years of executive-level experience in the healthcare industry. Most recently, Mr.Bruck was Executive Chairman of London-based Healthcare Enterprise Group Plc, a publicly traded company he funded and launched. From 1997-1999, he was CEO of Barbican Healthcare Plc, until it was successfully sold to BUPA, the largest private healthcare insurer in the UK. He holds a Master of Science in Health Services Administration from the State University of New York at Stony Brook.

"London & Pacific is beginning to expand operations," stated Mr.Bruck. "We are moving forward to ensure that we will be a focused organization with a best-in-class management team to capitalize on the tremendous opportunity in the healthcare sector today. Our vision is to provide our clients with extraordinary value and access to a highly specialized and experienced management team that can help guide them in every phase of their business development."

John May will hold day-to-day responsibilities as the Company's CFO and Deputy Chairman. He is currently a Director for the AIM-listed SPAC, Platinum Diversified Mining, Inc. Tomco Energy Plc, NASDAQ-listed Avatar Systems, Inc. and Southbank UK Plc, which recently floated on the Channel Islands Exchange. Previously, Mr. May was Finance Director for AIM-listed London & Boston Investments Plc until November 2005 and as a non-executive Director of AIM-listed Croma Group Plc until April 2005. In addition, he was previously a Senior Partner at Horwath Clark Whitehill, a UK accountancy firm, for 17 years, including eight years on the Managing Board.

As Senior Managing Director, Michael Low has over 25 years of experience in the healthcare industry in all aspects of business development, strategic planning and mergers and acquisitions. He has worked as a corporate executive with private and publicly-traded medical care organizations as well as major non-profit healthcare organizations, encompassing integrated healthcare delivery systems, hospital systems, physician practice management companies, managed care organizations and multi-specialty medical groups. Mr. Low has directed numerous acquisition, business development and strategic planning projects in the U.S., U.K., Europe and Asia. He joined Mr. Bruck in 1998 and in 2003 launched Healthcare Enterprise Group Plc, a publicly traded London-based firm where he served as Chief Development Officer until 2005. Prior to joining the Company, Mr. Low served as Vice President, Business Development, at AHI Healthcare Systems, and various posts held in business development, strategic planning and consulting capacities with UniHealth, Lutheran Hospital of So. California (LHS Corp) and National Medical Enterprises, Inc. He received his Masters of Public Administration, Health Services Administration from the University of Southern California.

Ed Robinson is CEO of the Pharmaceutical Services SPAC's HealthSPAC division. He has been involved in international contract research and development services for over 20 years. As former senior manager for Genecor International, Mr. Robinson guided a group that generated $300 million in sales from 1990 to 1997. During that time, he served on the board of a joint venture with Kyoma Kakko in Japan and negotiated the creation of a joint venture with an enzymes company in Wuxi, China. He later served as President of Lonza Biologics, where he helped grow sales threefold to $100 million. Mr. Robinson is currently a non-executive director at BAC BV of Naarden, s spin-off of Unilever, based in the Netherlands. He also serves as an advisor to Frost and Sullivan in the area of bio-manufacturing in India and on strategic life science investments in Europe and North America. Mr. Robinson earned his MBA in Management at Rochester Institute of Technology and his BSc from Clarkson University. He also completed an Advanced Management Program at Pennsylvania State University.

London & Pacific will be organized around its core businesses that capitalize on the emerging growth opportunities in the global healthcare industry. The company leaders are uniquely qualified to identify and pursue business opportunities for the benefit of its shareholders and client companies.

Rounding out the management team are additional executives, who are taking on expanded responsibilities and advisory roles:

Eric J. Weisman, Managing Director of the Company will oversee Investment Banking, Public Accounting and M&A strategies.

Derek Buchanan, Managing Director and CPA, will focus on Corporate Finance, M&A, and Financial Strategy within the life sciences sector.

Phil Dalton will serve as Senior Advisor and is currently CEO of Ridgecrest Healthcare Group, Inc., a Los Angeles-based publicly traded healthcare management company.

Michael Sinel, MD serves as Medical Advisor to London & Pacific Healthcare. He is a Board Certified, national expert in physical medicine, back pain and rehabilitation medicine and is a successful physician-entrepreneur.

About London & Pacific Healthcare, Inc.

London & Pacific Healthcare, Inc., formerly Latham Process Corp., has offices in the US and UK. The Company works with a select group of healthcare companies and organizations to create extraordinary value, growth and financial returns. London & Pacific focuses its broad expertise in operational, regulatory and financial skills to achieve outstanding results for London & Pacific clients, partners and investors. For additional information and management biographies, please visit the corporate website at

Safe Harbor Disclaimer: This news release contains forward-looking statements that are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of such forward-looking statements. Such forward-looking statements are made based upon management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Private Securities Litigation Reform Act of 1995.

Contact Information